![](/img/cover-not-exists.png)
A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosis
Verstovsek, Srdan, Savona, Michael R., Mesa, Ruben A., Dong, Hua, Maltzman, Julia D., Sharma, Shringi, Silverman, Jeffrey, Oh, Stephen T., Gotlib, JasonVolume:
176
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.14501
Date:
March, 2017
File:
PDF, 711 KB
english, 2017